Profile picture

Doctor Anne-Floor Barbara Eleonore Quast

Academic Medical Centre, Amsterdam (Netherlands (The))
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Minimal defibrillation thresholds determined by step-down defibrillation testing in subcutaneous implantable-defibrillator patients during implantation and replacement.
Presentation
Minimal defibrillation thresholds determined by step-down defibrillation testing in subcutaneous implantable-defibrillator patients during implantation and replacement.
Myocardial damage as a result of implantation and defibrillation testing in transvenous and subcutaneous implantable cardioverter-defibrillators.
Presentation
Myocardial damage as a result of implantation and defibrillation testing in transvenous and subcutaneous implantable cardioverter-defibrillators.
The correlation between the PRAETORIAN Score in Subcutaneous Implantable Defibrillator Patients and the Defibrillation Threshold.
Presentation
The correlation between the PRAETORIAN Score in Subcutaneous Implantable Defibrillator Patients and the Defibrillation Threshold.
Device orientation of a leadless pacemaker and subcutaneous implantable cardioverter-defibrillator in canine and human subjects and the effect on device-device communication.
Presentation
Device orientation of a leadless pacemaker and subcutaneous implantable cardioverter-defibrillator in canine and human subjects and the effect on device-device communication.
Impact of device orientation on device-device communication between a leadless pacemaker and a subcutaneous implantable cardioverter-defibrillator in an acute and chronic setting.
Presentation
Impact of device orientation on device-device communication between a leadless pacemaker and a subcutaneous implantable cardioverter-defibrillator in an acute and chronic setting.
Determining Subcuteneous-ICD suitability: Predictors of appropriate antitachycardia pacing therapy.
Presentation
Determining Subcuteneous-ICD suitability: Predictors of appropriate antitachycardia pacing therapy.
Six year follow-up of the initial dutch subcutaneous implantable cardioverter-defibrillator cohort: Long term complications and battery longevity.
Presentation
Six year follow-up of the initial dutch subcutaneous implantable cardioverter-defibrillator cohort: Long term complications and battery longevity.

ESC 365 is supported by